Enter Note Done
Go to previous page in this tab
Event
  • Informational Session
  • Bookmark Icon
  • When Other Species Bail on You, Minipig to the Rescue: An Evidence-Based Alternative for DART and Juvenile Toxicology Programs
  • Schedule
    Notes
  • Stars at Night Ballroom B2‚ Convention Center
    Set Timezone


Chair: Marie Bouressam, Charles River Laboratories, France
Co-Chair: Steven Van Cruchten, University of Antwerp, Belgium

Primary Endorser: Reproductive and Developmental Toxicology Specialty Section


Endorser(s): Comparative Toxicology, Pathology, and Veterinary Specialty Section


The minipig is recognized as a non-routine species for developmental and reproductive toxicity (DART) testing and for nonclinical safety assessment supporting pediatric drug development in the most recent International Council for Harmonisation guidelines (ICH S5(R3) and ICH S11). Despite this regulatory acknowledgment, the minipig remains infrequently used in DART and juvenile toxicology programs. When routine species are unsuitable, cynomolgus monkey (NHP) are still commonly selected, sometimes by default rather than through a systematic, science-based evaluation of alternative models. This session will provide a critical and balanced assessment of the minipig as an alternative non-rodent species for DART and juvenile toxicology testing, integrating biological relevance, practical feasibility, and regulatory considerations. By drawing on comparative developmental biology, nonclinical practical experience and current regulatory perspectives, speakers will address why the minipig remains underutilized and how this gap can be bridged through proactive engagement with health authorities to establish appropriately designed and executed studies. Presentations will first explore key aspects of minipig physiology relevant to DART and pediatric applications, including sexual maturation, organ system development, and neurobehavioral assessment, with emphasis on similarities and differences relative to human development. Comparative data will highlight where the juvenile minipig offers improved translational relevance compared with traditional rodent and canine models, particularly for pediatric-only indications and early life exposure scenarios. The session will then address commonly perceived barriers to the broader adoption of the minipig in DART programs, including logistical considerations, housing and training requirements and study design constraints. Through concrete DART and juvenile toxicology case examples, speakers will explain how these challenges can be anticipated and mitigated through early planning and exploitation of existing scientific and technical expertise using appropriate infrastructures. Finally, scientific considerations for species selection and justification will be discussed in a regulatory context and how dialogue with regulators can highlight the pros and cons for using the minipig as an alternative to NHPs. Collectively, the presentations aim to provide toxicologists, nonclinical scientists and regulatory professionals with practical, actionable guidance on when and how the minipig can be scientifically and ethically justified and used in DART and juvenile toxicology programs.
Session and Activity Type
Presentations